Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132918) titled 'HEARTS Trial for Thoracic Cancers' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of Wisconsin, Madison
Condition:
Non-Small Cell Lung Cancer (Stage III)
Esophageal Cancer Stage I-III
Esophagogastric Cancer Stage I-III
Thymoma and Thymic Carcinoma Stage II-III
Other Cancers in the Thoracic Region
Intervention:
Radiation: MRgART
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: September 2025
Target Sample Size: 60
Countries ...